BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 28117027)

  • 21. Long Noncoding RNA SNHG16 Sponges miR-182-5p And miR-128-3p To Promote Retinoblastoma Cell Migration And Invasion By Targeting LASP1.
    Yang L; Zhang L; Lu L; Wang Y
    Onco Targets Ther; 2019; 12():8653-8662. PubMed ID: 31806989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-133b is a potential diagnostic biomarker for Alzheimer's disease and has a neuroprotective role.
    Yang Q; Zhao Q; Yin Y
    Exp Ther Med; 2019 Oct; 18(4):2711-2718. PubMed ID: 31572518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New Frontiers for the Cytoskeletal Protein LASP1.
    Butt E; Raman D
    Front Oncol; 2018; 8():391. PubMed ID: 30298118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-302 inhibits cell migration and invasion in cervical cancer by targeting DCUN1D1.
    Jiang Y; Hou R; Li S; Li S; Dang G
    Exp Ther Med; 2018 Aug; 16(2):1000-1008. PubMed ID: 30116351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-599 suppresses glioma progression by targeting RAB27B.
    Jiang Y; Wang X; Zhang J; Lai R
    Oncol Lett; 2018 Jul; 16(1):1243-1252. PubMed ID: 29963197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-142-3p inhibits cell proliferation and chemoresistance in ovarian cancer via targeting sirtuin 1.
    Gao J; Wu N; Liu X; Xia Y; Chen Y; Li S; Deng Z
    Exp Ther Med; 2018 Jun; 15(6):5205-5214. PubMed ID: 29904404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR‑133b regulates proliferation and apoptosis in high‑glucose‑induced human retinal endothelial cells by targeting ras homolog family member A.
    Yao J; Wang J; Yao Y; Wang K; Zhou Q; Tang Y
    Int J Mol Med; 2018 Aug; 42(2):839-850. PubMed ID: 29786744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA‑195 inhibits cell proliferation, migration and invasion by targeting defective in cullin neddylation 1 domain containing 1 in cervical cancer.
    Zhong J; Yuan H; Xu X; Kong S
    Int J Mol Med; 2018 Aug; 42(2):779-788. PubMed ID: 29750306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-133a acts as a tumour suppressor in breast cancer through targeting LASP1.
    Sui Y; Zhang X; Yang H; Wei W; Wang M
    Oncol Rep; 2018 Feb; 39(2):473-482. PubMed ID: 29207145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LASP1 in Cellular Signaling and Gene Expression: More than Just a Cytoskeletal Regulator.
    Butt E; Howard CM; Raman D
    Cells; 2022 Nov; 11(23):. PubMed ID: 36497077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-133b Inhibits Proliferation, Cellular Migration, and Invasion via Targeting LASP1 in Hepatocarcinoma Cells.
    Li H; Xiang Z; Liu Y; Xu B; Tang J
    Oncol Res; 2017 Sep; 25(8):1269-1282. PubMed ID: 28117027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-326 inhibits cell proliferation and invasion, activating apoptosis in hepatocellular carcinoma by directly targeting LIM and SH3 protein 1.
    Hu S; Ran Y; Chen W; Zhang Y; Xu Y
    Oncol Rep; 2017 Sep; 38(3):1569-1578. PubMed ID: 28713953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased long noncoding RNA LASP1-AS is critical for hepatocellular carcinoma tumorigenesis via upregulating LASP1.
    Yin L; Chen Y; Zhou Y; Deng G; Han Y; Guo C; Li Y; Zeng S; Shen H
    J Cell Physiol; 2019 Aug; 234(8):13493-13509. PubMed ID: 30677131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long non-coding RNA (lncRNA) CYTOR promotes hepatocellular carcinoma proliferation by targeting the microRNA-125a-5p/LASP1 axis.
    Liu Y; Geng X
    Bioengineered; 2022 Feb; 13(2):3666-3679. PubMed ID: 35081873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-133b inhibits hepatocellular carcinoma cell progression by targeting Sirt1.
    Tian Z; Jiang H; Liu Y; Huang Y; Xiong X; Wu H; Dai X
    Exp Cell Res; 2016 May; 343(2):135-147. PubMed ID: 27090017
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.